药物信息为Azulfidine EN-tabs sulfasalazine delayed release tablets, USP (Pharmacia and Upjohn Company): DESCRIPTION
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- DRUG ABUSE AND DEPENDENCE
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- REFERENCES
- PRINCIPAL DISPLAY PANEL - 500 mg tablet bottle
- 外部链接相关的Azulfidine EN-tabs sulfasalazine delayed release tablets, USP (Pharmacia and Upjohn Company)
AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.
AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tablet in the stomach and reduce potential irritation of the gastric mucosa.
Therapeutic Classification: Anti-inflammatory agent and/or immunomodulatory agent.
Chemical Designation: 5-([p-(2-pyridylsulfamoyl) phenyl]azo) salicylic acid.
Chemical Structure:

Molecular Formula: C18H14N4O5S
- Drug Information Provided by National Library of Medicine (NLM).
